drugset / Trial / NCT00404534

Helicobacter Eradication Relief of Dyspeptic Symptoms

NCT00404534

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A double-blind clinical trial investigating if a sub-group of functional dyspeptic patients without any use of NSAID or gastric erosions could have a better evolution of their dyspeptic symptoms after Helicobacter eradication than the placebo control group

Timeline

Start
2006-10
Primary completion
2009-06
Completion
2009-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 1000 mg
Subject Clarithromycin Small molecule 500 mg
Background Omeprazole Other / unclassified 20 mg

Indications